This is a synthetic peptide designed for use in combination with anti-PLEKHG2 Antibody(ARP59650_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Restrictions
For Research Use only
Format
Lyophilized
Reconstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Concentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Conseil sur la manipulation
Avoid repeated freeze-thaw cycles.
Stock
-20 °C
Stockage commentaire
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Antigène
PLEKHG2
(Pleckstrin Homology Domain Containing, Family G (With RhoGef Domain) Member 2 (PLEKHG2))
Synonymes
ARHGEF42 Peptide, CLG Peptide, AI194308 Peptide, Clg Peptide, Cslg Peptide, pleckstrin homology and RhoGEF domain containing G2 Peptide, pleckstrin homology domain containing, family G (with RhoGef domain) member 2 Peptide, PLEKHG2 Peptide, Plekhg2 Peptide
Sujet
PLEKHG2 may be a transforming oncogene with exchange activity for CDC42. PLEKHG2 may be a guanine-nucleotide exchange factor (GEF) for RAC1 and CDC42.PLEKHG2 activated by the binding to subunits beta and gamma of the heterotrimeric guanine nucleotide-binding protein (G protein).
Alias Symbols: CLG, DKFZp667J2325, FLJ00018, FLJ22458, FLJ38638, ARHGEF42
Protein Interaction Partner: CDC42,RAC1,RHOA,CDC42,RAC1,RHOA